MUSASHI-2 duels in myelodysplastic syndromes.
a Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Tzu-Chieh
TC
Ho
a Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
James
J
Taggart
a Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Michael G
MG
Kharas
D006801:Humans; D009154:Mutation; D009190:Myelodysplastic Syndromes; D016601:RNA-Binding Proteins
D016601:RNA-Binding Proteins